Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
396.2 INR | -0.46% | -6.19% | -2.27% |
30/04 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
15/04 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.27% | 1.15B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit